United States
Germany
Japan
United Kingdom
China
Products
MAP2K1 (untagged)-Kinase deficient mutant (K97M) of Human mitogen-activated protein kinase kinase 1 (MAP2K1)
| Type | Human Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-XL4 |
Anti-MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI1F5 (formerly 1F5)
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
Anti-MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI1C1 (formerly 1C1)
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI7F3 (formerly 7F3)
| Applications | IF, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI8H1 (formerly 8H1)
| Applications | IF, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI1F4 (formerly 1F4)
| Applications | IF, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI5F5 (formerly 5F5)
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
活动过滤器
优化搜索结果
Species
Reactivities
Antibody Hosts
Expression Hosts
Lentivirus
Vectors
Knockout (KO) Validation
Conjugates
Isotypes
Clonalities
Assay Types
QC Levels
Families
Pathways
- Acute myeloid leukemia (98)
- B cell receptor signaling pathway (98)
- Bladder cancer (98)
- Chemokine signaling pathway (98)
- Chronic myeloid leukemia (98)
- Colorectal cancer (98)
- Dorso-ventral axis formation (98)
- Endometrial cancer (98)
- ErbB signaling pathway (98)
- Fc epsilon RI signaling pathway (98)
- Fc gamma R-mediated phagocytosis (98)
- Focal adhesion (98)
- Gap junction (98)
- Glioma (98)
- GnRH signaling pathway (98)
- Insulin signaling pathway (98)
- Long-term depression (98)
- Long-term potentiation (98)
- MAPK signaling pathway (98)
- Melanogenesis (98)
- Melanoma (98)
- Natural killer cell mediated cytotoxicity (98)
- Neurotrophin signaling pathway (98)
- Non-small cell lung cancer (98)
- Oocyte meiosis (98)
- Pancreatic cancer (98)
- Pathways in cancer (98)
- Prion diseases (98)
- Progesterone-mediated oocyte maturation (98)
- Prostate cancer (98)
- Regulation of actin cytoskeleton (98)
- Renal cell carcinoma (98)
- T cell receptor signaling pathway (98)
- Thyroid cancer (98)
- Toll-like receptor signaling pathway (98)
- VEGF signaling pathway (98)
- Vascular smooth muscle contraction (98)
